Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

9.1%

1 terminated/withdrawn out of 11 trials

Success Rate

88.9%

+2.4% vs industry average

Late-Stage Pipeline

27%

3 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(50.0%)
Phase 3
3(37.5%)
Phase 2
1(12.5%)
8Total
N/A(4)
Phase 3(3)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (11)